GeneDx Holdings Corp. (WGS)
WGS trades on Nasdaq in Health Care, Medical/Nursing Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1818331/000181833126000015/0001818331-26-000015-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | WGS on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Nursing Services |
| Country | United States |
| IPO year | 2020 |
| SEC CIK | 0001818331 |
| SEC industry code | Services-Health Services |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $427.5M |
| Net income | -$21.0M |
| Operating income | -$13.1M |
| Net margin | -4.9% |
| Operating margin | -3.1% |
| Revenue growth | +40.0% |
| Cash | $105.0M |
| Total assets | $523.7M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 3.6× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-09 |
| Cash and burn | $96.1M cash; operating cash flow -$18.8M a quarter. | Report 2026-09-30 |
| Shares outstanding | 29,972,493 (2026-11-02); 28,904,590 a year earlier; 25,884,279 three years earlier. | Cover page 2026-11-02 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Delisting | 25-NSE filed | 25-NSE 2026-07-21 |
| Auditor | Ernst & Young LLP, New York, New York, United States | PCAOB Form AP 2026-03-02 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $106.6M, sold $21.8M on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $123.1M | -$12.3M | -$10.6M | $96.1M | $150.0M | $460.8M | 10-Q 2026-11-09 |
| Q2 2026 2026-06-30 | $114.4M | -$17.7M | -$29.0M | $60.3M | $100.0M | $454.4M | 10-Q 2026-08-03 |
| Q1 2026 2026-03-31 | $102.3M | -$63.3M | -$32.4M | $93.9M | $100.0M | $442.7M | 10-Q 2026-05-04 |
| Q4 2025 2025-12-31 | $121.0M | -$17.7M | -$3.1M | $105.0M | $54.5M | $427.5M | 10-K 2026-02-23 |
| Q3 2025 2025-09-30 | $116.7M | -$7.6M | $15.8M | $96.0M | $54.8M | $402.2M | 10-Q 2026-11-09 |
| Q2 2025 2025-06-30 | $102.7M | $10.8M | $10.4M | $74.1M | $55.1M | $362.3M | 10-Q 2026-08-03 |
| Q1 2025 2025-03-31 | $87.1M | -$6.5M | $10.2M | $99.7M | $55.5M | $330.1M | 10-Q 2026-05-04 |
| Q4 2024 2024-12-31 | $95.6M | $5.4M | -$3.2M | $85.2M | $55.8M | $305.4M | 10-K 2026-02-23 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3ASR | 2025-10-28 |
| Latest annual report | 10-K | 2026-02-23 |
| Latest quarterly / interim | 10-Q | 2026-11-09 |
| Latest current report | 8-K | 2026-11-09 |
| Latest proxy | DEFA14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 785 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -16.0% |
| 1 month | -19.4% |
| 3 months | -33.8% |
| Year to date | -59.7% |
| 1 year | -59.8% |
| From 52-week high | -68.7% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Nursing Services
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| USPH | U.S. Physical Therapy Inc. | $99.55 | +0.41% | $1.5B |
| TDOC | Teladoc Health Inc. | $8.70 | -1.14% | $1.6B |
| INNV | InnovAge Holding Corp. | $9.58 | +1.16% | $1.3B |
| PNTG | The Pennant Group Inc. Common Stock | $37.03 | +2.66% | $1.3B |
| AHCO | AdaptHealth Corp. | $7.73 | +0.91% | $1.1B |
| ADUS | Addus HomeCare Corporation | $124.61 | +1.31% | $2.3B |
| AVAH | Aveanna Healthcare Holdings Inc. | $11.63 | +1.13% | $2.5B |
| OMDA | Omada Health Inc. | $14.49 | +1.12% | $898.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier